Elon Musk is in Germany this week to discuss a collaboration with CureVac to build RNA microfactories, which could help vaccine development.
BigField GEG Tech's insight:
Elon Musk is looking to contribute Tesla’s tech resources to the battle against the coronavirus pandemic, again—despite having been dead wrong about the virus several times over the last five months.
The cooperation between CureVac and Tesla’s Grohmann unit was first made public in July, when Musk tweeted that Tesla was looking into RNA microfactories “as a side project.”
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
Elon Musk is looking to contribute Tesla’s tech resources to the battle against the coronavirus pandemic, again—despite having been dead wrong about the virus several times over the last five months.
The cooperation between CureVac and Tesla’s Grohmann unit was first made public in July, when Musk tweeted that Tesla was looking into RNA microfactories “as a side project.”